Կաննաբինոիդներ (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Կաննաբինոիդներ" in Armenian language version.

refsWebsite

Global rank Armenian rank

47nih.gov

4^th place

3^rd place

35doi.org

2^nd place

4^th place

9archive.org

6^th place

2unodc.org

2,494^th place

1,729^th place

1worldcat.org

5^th place

10^th place

1faqs.org

4,871^st place

9,530^th place

1nbcbayarea.com

6,487^th place

low place

1web.archive.org

1^st place

1marijuana.org

low place

archive.org

Pertwee, Roger, ed. (2005). Cannabinoids. Springer-Verlag. էջ 2. ISBN 3-540-22565-X.
Boron, Walter F.; Boulpaep, Emile L., eds. (2009). Medical Physiology: A Cellular and Molecular Approach. Saunders. էջ 331. ISBN 978-1-4160-3115-4.
Campbell, V A; Gowran, A (2007). «Alzheimer's disease; taking the edge off with cannabinoids?». British Journal of Pharmacology. 152 (5): 655–62. doi:10.1038/sj.bjp.0707446. PMC 2190031. PMID 17828287.
Ligresti, A.; Moriello, AS; Starowicz, K; Matias, I; Pisanti, S; De Petrocellis, L; Laezza, C; Portella, G; Bifulco, M; Di Marzo, V (2006). «Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma». Journal of Pharmacology and Experimental Therapeutics. 318 (3): 1375–87. doi:10.1124/jpet.106.105247. PMID 16728591.
Thomas, Adèle; Stevenson, Lesley A; Wease, Kerrie N; Price, Martin R; Baillie, Gemma; Ross, Ruth A; Pertwee, Roger G (2005). «Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1and CB2receptor antagonist». British Journal of Pharmacology. 146 (7): 917–26. doi:10.1038/sj.bjp.0706414. PMC 1751228. PMID 16205722.
Merkus, Frans W. H. M. (1971). «Cannabivarin and Tetrahydrocannabivarin, Two New Constituents of Hashish». Nature. 232 (5312): 579–80. doi:10.1038/232579a0. PMID 4937510.
Chapman, K. D.; Venables, B; Markovic, R; Blair Jr, RW; Bettinger, C (1999). «N-Acylethanolamines in Seeds. Quantification of Molecular Species and Their Degradation upon Imbibition». Plant Physiology. 120 (4): 1157–64. doi:10.1104/pp.120.4.1157. PMC 59349. PMID 10444099.
Savinainen, Juha R; Järvinen, Tomi; Laine, Krista; Laitinen, Jarmo T (2001). «Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1receptor-dependent G-protein activation in rat cerebellar membranes». British Journal of Pharmacology. 134 (3): 664–72. doi:10.1038/sj.bjp.0704297. PMC 1572991. PMID 11588122.
Bisogno, T; Ligresti, A; Dimarzo, V (2005). «The endocannabinoid signalling system: Biochemical aspects». Pharmacology Biochemistry and Behavior. 81 (2): 224–38. doi:10.1016/j.pbb.2005.01.027. PMID 15935454.

doi.org

Pacher, P.; Bátkai, S; Kunos, G (2006). «The Endocannabinoid System as an Emerging Target of Pharmacotherapy». Pharmacological Reviews. 58 (3): 389–462. doi:10.1124/pr.58.3.2. PMC 2241751. PMID 16968947.
Lambert, Didier M.; Fowler, Christopher J. (2005). «The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications». Journal of Medicinal Chemistry. 48 (16): 5059–87. doi:10.1021/jm058183t. PMID 16078824.
El-Alfy, Abir T.; Ivey, Kelly; Robinson, Keisha; Ahmed, Safwat; Radwan, Mohamed; Slade, Desmond; Khan, Ikhlas; Elsohly, Mahmoud; Ross, Samir (2010). «Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L». Pharmacology Biochemistry and Behavior. 95 (4): 434–42. doi:10.1016/j.pbb.2010.03.004. PMC 2866040. PMID 20332000.
Begg, Malcolm; Pacher, Pál; Batkai, Sándor; Oseihyiaman, Douglas; Offertaler, László; Mo, Fong Ming; Liu, Jie; Kunos, George (2005). «Evidence for novel cannabinoid receptors». Pharmacology & Therapeutics. 106 (2): 133–45. doi:10.1016/j.pharmthera.2004.11.005. PMID 15866316.
Pacher, P.; Mechoulam, R. (2011). «Is lipid signaling through cannabinoid 2 receptors part of a protective system?». Progress in Lipid Research. 50 (2): 193–211. doi:10.1016/j.plipres.2011.01.001. PMC 3062638. PMID 21295074.
Fellermeier, Monika; Eisenreich, Wolfgang; Bacher, Adelbert; Zenk, Meinhart H. (2001). «Biosynthesis of cannabinoids». European Journal of Biochemistry. 268 (6): 1596–1604. doi:10.1046/j.1432-1327.2001.02030.x. ISSN 0014-2956. PMID 11248677.
Campbell, V A; Gowran, A (2007). «Alzheimer's disease; taking the edge off with cannabinoids?». British Journal of Pharmacology. 152 (5): 655–62. doi:10.1038/sj.bjp.0707446. PMC 2190031. PMID 17828287.
Huffman, J. (2000). «The Search for Selective Ligands for the CB2 Receptor». Current Pharmaceutical Design. 6 (13): 1323–37. doi:10.2174/1381612003399347. PMID 10903395.
Ilan, A. B.; Gevins, A.; Coleman, M.; Elsohly, M. A.; De Wit, H. (2005). «Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids». Behavioural Pharmacology. 16 (5–6): 487–96. doi:10.1097/00008877-200509000-00023. PMID 16148455.
Morgan, C. J. A.; Curran, H. V. (2008). «Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis». The British Journal of Psychiatry. 192 (4): 306–7. doi:10.1192/bjp.bp.107.046649. PMID 18378995.
Mechoulam, Raphael; Peters, Maximilian; Murillo-Rodriguez, Eric; Hanuš, Lumír O. (2007). «Cannabidiol – Recent Advances». Chemistry & Biodiversity. 4 (8): 1678–92. doi:10.1002/cbdv.200790147. PMID 17712814.
Ryberg, E; Larsson, N; Sjögren, S; Hjorth, S; Hermansson, N-O; Leonova, J; Elebring, T; Nilsson, K; Drmota, T; Greasley, P J (2009). «The orphan receptor GPR55 is a novel cannabinoid receptor». British Journal of Pharmacology. 152 (7): 1092–101. doi:10.1038/sj.bjp.0707460. PMC 2095107. PMID 17876302.
Russo, Ethan B.; Burnett, Andrea; Hall, Brian; Parker, Keith K. (2005). «Agonistic Properties of Cannabidiol at 5-HT1a Receptors». Neurochemical Research. 30 (8): 1037–43. doi:10.1007/s11064-005-6978-1. PMID 16258853.
Leweke, F M; Piomelli, D; Pahlisch, F; Muhl, D; Gerth, C W; Hoyer, C; Klosterkötter, J; Hellmich, M; Koethe, D (2012). «Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia». Translational Psychiatry. 2 (3): e94–. doi:10.1038/tp.2012.15. PMC 3316151. PMID 22832859.
McAllister, S. D.; Christian, R. T.; Horowitz, M. P.; Garcia, A.; Desprez, P.-Y. (2007). «Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells». Molecular Cancer Therapeutics. 6 (11): 2921–7. doi:10.1158/1535-7163.MCT-07-0371. PMID 18025276.
Ligresti, A.; Moriello, AS; Starowicz, K; Matias, I; Pisanti, S; De Petrocellis, L; Laezza, C; Portella, G; Bifulco, M; Di Marzo, V (2006). «Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma». Journal of Pharmacology and Experimental Therapeutics. 318 (3): 1375–87. doi:10.1124/jpet.106.105247. PMID 16728591.
Mahadevan, Anu; Siegel, Craig; Martin, Billy R.; Abood, Mary E.; Beletskaya, Irina; Razdan, Raj K. (2000). «Novel Cannabinol Probes for CB1 and CB2 Cannabinoid Receptors». Journal of Medicinal Chemistry. 43 (20): 3778–85. doi:10.1021/jm0001572. PMID 11020293.
Cascio, MG; Gauson, LA; Stevenson, LA; Ross, RA; Pertwee, RG (2010). «Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist». British Journal of Pharmacology. 159 (1): 129–41. doi:10.1111/j.1476-5381.2009.00515.x. PMC 2823359. PMID 20002104.
Hillig, K. W.; Mahlberg, P. G. (2004). «A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae)». American Journal of Botany. 91 (6): 966–75. doi:10.3732/ajb.91.6.966. PMID 21653452.
Thomas, Adèle; Stevenson, Lesley A; Wease, Kerrie N; Price, Martin R; Baillie, Gemma; Ross, Ruth A; Pertwee, Roger G (2005). «Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1and CB2receptor antagonist». British Journal of Pharmacology. 146 (7): 917–26. doi:10.1038/sj.bjp.0706414. PMC 1751228. PMID 16205722.
Merkus, Frans W. H. M. (1971). «Cannabivarin and Tetrahydrocannabivarin, Two New Constituents of Hashish». Nature. 232 (5312): 579–80. doi:10.1038/232579a0. PMID 4937510.
Grotenhermen, Franjo (2005). «Cannabinoids». Current Drug Target -CNS & Neurological Disorders. 4 (5): 507–530. doi:10.2174/156800705774322111.
Martin, B.R.; Mechoulam, R.; Razdan, R.K. (1999). «Discovery and characterization of endogenous cannabinoids». Life Sciences. 65 (6–7): 573–595. doi:10.1016/S0024-3205(99)00281-7.
Di Tomaso, Emmanuelle; Beltramo, Massimiliano; Piomelli, Daniele (1996). «Brain cannabinoids in chocolate». Nature. 382 (6593): 677–8. doi:10.1038/382677a0. PMID 8751435.
Chapman, K. D.; Venables, B; Markovic, R; Blair Jr, RW; Bettinger, C (1999). «N-Acylethanolamines in Seeds. Quantification of Molecular Species and Their Degradation upon Imbibition». Plant Physiology. 120 (4): 1157–64. doi:10.1104/pp.120.4.1157. PMC 59349. PMID 10444099.
Sepe, Nunzio; De Petrocellis, Luciano; Montanaro, Francesca; Cimino, Guido; Di Marzo, Vincenzo (1998). «Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs». Biochimica et Biophysica Acta (BBA) – Lipids and Lipid Metabolism. 1389 (2): 101–11. doi:10.1016/S0005-2760(97)00132-X. PMID 9461251.
Piomelli, Daniele; Schweitzer, Nephi; Piomelli, Paul (1997). «A second endogenous cannabinoid that modulates long-term potentiation». Nature. 388 (6644): 773–8. doi:10.1038/42015. PMID 9285589.
Savinainen, Juha R; Järvinen, Tomi; Laine, Krista; Laitinen, Jarmo T (2001). «Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1receptor-dependent G-protein activation in rat cerebellar membranes». British Journal of Pharmacology. 134 (3): 664–72. doi:10.1038/sj.bjp.0704297. PMC 1572991. PMID 11588122.
Hanuš, Lumír; Abu-Lafi, Saleh; Fride, Ester; Breuer, Aviva; Vogel, Zvi; Shalev, Deborah E.; Kustanovich, Irina; Mechoulam, Raphael (2001). «2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor». Proceedings of the National Academy of Sciences. 98 (7): 3662–5. doi:10.1073/pnas.061029898. PMC 31108. PMID 11259648.
Oka, Saori; Tsuchie, Akiko; Tokumura, Akira; Muramatsu, Mayumi; Suhara, Yoshitomo; Takayama, Hiroaki; Waku, Keizo; Sugiura, Takayuki (2003). «Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species». Journal of Neurochemistry. 85 (6): 1374–81. doi:10.1046/j.1471-4159.2003.01804.x. PMID 12787057.
Bisogno, Tiziana; Melck, Dominique; Bobrov, Mikhail Yu.; Gretskaya, Natalia M.; Bezuglov, Vladimir V.; De Petrocellis, Luciano; Di Marzo, Vincenzo (2000). «N-acyl-dopamines: Novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo». Biochemical Journal. 351 (3): 817–24. doi:10.1042/0264-6021:3510817. PMC 1221424. PMID 11042139.
Bisogno, T; Ligresti, A; Dimarzo, V (2005). «The endocannabinoid signalling system: Biochemical aspects». Pharmacology Biochemistry and Behavior. 81 (2): 224–38. doi:10.1016/j.pbb.2005.01.027. PMID 15935454.
Ralevic, Vera (2003). «Cannabinoid modulation of peripheral autonomic and sensory neurotransmission». European Journal of Pharmacology. 472 (1–2): 1–21. doi:10.1016/S0014-2999(03)01813-2. PMID 12860468.
Porter, A. C.; Sauer, JM; Knierman, MD; Becker, GW; Berna, MJ; Bao, J; Nomikos, GG; Carter, P; Bymaster, FP; Leese, AB; Felder, CC (2002). «Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor». Journal of Pharmacology and Experimental Therapeutics. 301 (3): 1020–4. doi:10.1124/jpet.301.3.1020. PMID 12023533.
Piñeiro, Roberto; Falasca, Marco (2012). «Lysophosphatidylinositol signalling: New wine from an old bottle». Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids. 1821 (4): 694–705. doi:10.1016/j.bbalip.2012.01.009. PMID 22285325.

faqs.org

Patentdocs. Patent application title: Controlled cannabis decarboxylation. US Patent application number: 20120046352. Retrieved 28 December, 2013

marijuana.org

«More medicinal uses for marijuana». Marijuana.org. 2005 թ․ հոկտեմբերի 18. Արխիվացված է օրիգինալից 2005 թ․ դեկտեմբերի 21-ին. Վերցված է 2014 թ․ հունվարի 15-ին.

nbcbayarea.com

«Marijuana Compound Fights Cancer; Human Trials Next». NBC Bay Area.

nih.gov

pubmed.ncbi.nlm.nih.gov

Pacher, P.; Bátkai, S; Kunos, G (2006). «The Endocannabinoid System as an Emerging Target of Pharmacotherapy». Pharmacological Reviews. 58 (3): 389–462. doi:10.1124/pr.58.3.2. PMC 2241751. PMID 16968947.
Lambert, Didier M.; Fowler, Christopher J. (2005). «The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications». Journal of Medicinal Chemistry. 48 (16): 5059–87. doi:10.1021/jm058183t. PMID 16078824.
El-Alfy, Abir T.; Ivey, Kelly; Robinson, Keisha; Ahmed, Safwat; Radwan, Mohamed; Slade, Desmond; Khan, Ikhlas; Elsohly, Mahmoud; Ross, Samir (2010). «Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L». Pharmacology Biochemistry and Behavior. 95 (4): 434–42. doi:10.1016/j.pbb.2010.03.004. PMC 2866040. PMID 20332000.
Begg, Malcolm; Pacher, Pál; Batkai, Sándor; Oseihyiaman, Douglas; Offertaler, László; Mo, Fong Ming; Liu, Jie; Kunos, George (2005). «Evidence for novel cannabinoid receptors». Pharmacology & Therapeutics. 106 (2): 133–45. doi:10.1016/j.pharmthera.2004.11.005. PMID 15866316.
Pacher, P.; Mechoulam, R. (2011). «Is lipid signaling through cannabinoid 2 receptors part of a protective system?». Progress in Lipid Research. 50 (2): 193–211. doi:10.1016/j.plipres.2011.01.001. PMC 3062638. PMID 21295074.
Fellermeier, Monika; Eisenreich, Wolfgang; Bacher, Adelbert; Zenk, Meinhart H. (2001). «Biosynthesis of cannabinoids». European Journal of Biochemistry. 268 (6): 1596–1604. doi:10.1046/j.1432-1327.2001.02030.x. ISSN 0014-2956. PMID 11248677.
Campbell, V A; Gowran, A (2007). «Alzheimer's disease; taking the edge off with cannabinoids?». British Journal of Pharmacology. 152 (5): 655–62. doi:10.1038/sj.bjp.0707446. PMC 2190031. PMID 17828287.
Huffman, J. (2000). «The Search for Selective Ligands for the CB2 Receptor». Current Pharmaceutical Design. 6 (13): 1323–37. doi:10.2174/1381612003399347. PMID 10903395.
Ilan, A. B.; Gevins, A.; Coleman, M.; Elsohly, M. A.; De Wit, H. (2005). «Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids». Behavioural Pharmacology. 16 (5–6): 487–96. doi:10.1097/00008877-200509000-00023. PMID 16148455.
Morgan, C. J. A.; Curran, H. V. (2008). «Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis». The British Journal of Psychiatry. 192 (4): 306–7. doi:10.1192/bjp.bp.107.046649. PMID 18378995.
Mechoulam, Raphael; Peters, Maximilian; Murillo-Rodriguez, Eric; Hanuš, Lumír O. (2007). «Cannabidiol – Recent Advances». Chemistry & Biodiversity. 4 (8): 1678–92. doi:10.1002/cbdv.200790147. PMID 17712814.
Ryberg, E; Larsson, N; Sjögren, S; Hjorth, S; Hermansson, N-O; Leonova, J; Elebring, T; Nilsson, K; Drmota, T; Greasley, P J (2009). «The orphan receptor GPR55 is a novel cannabinoid receptor». British Journal of Pharmacology. 152 (7): 1092–101. doi:10.1038/sj.bjp.0707460. PMC 2095107. PMID 17876302.
Russo, Ethan B.; Burnett, Andrea; Hall, Brian; Parker, Keith K. (2005). «Agonistic Properties of Cannabidiol at 5-HT1a Receptors». Neurochemical Research. 30 (8): 1037–43. doi:10.1007/s11064-005-6978-1. PMID 16258853.
Leweke, F M; Piomelli, D; Pahlisch, F; Muhl, D; Gerth, C W; Hoyer, C; Klosterkötter, J; Hellmich, M; Koethe, D (2012). «Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia». Translational Psychiatry. 2 (3): e94–. doi:10.1038/tp.2012.15. PMC 3316151. PMID 22832859.
McAllister, S. D.; Christian, R. T.; Horowitz, M. P.; Garcia, A.; Desprez, P.-Y. (2007). «Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells». Molecular Cancer Therapeutics. 6 (11): 2921–7. doi:10.1158/1535-7163.MCT-07-0371. PMID 18025276.
Ligresti, A.; Moriello, AS; Starowicz, K; Matias, I; Pisanti, S; De Petrocellis, L; Laezza, C; Portella, G; Bifulco, M; Di Marzo, V (2006). «Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma». Journal of Pharmacology and Experimental Therapeutics. 318 (3): 1375–87. doi:10.1124/jpet.106.105247. PMID 16728591.
Mahadevan, Anu; Siegel, Craig; Martin, Billy R.; Abood, Mary E.; Beletskaya, Irina; Razdan, Raj K. (2000). «Novel Cannabinol Probes for CB1 and CB2 Cannabinoid Receptors». Journal of Medicinal Chemistry. 43 (20): 3778–85. doi:10.1021/jm0001572. PMID 11020293.
Cascio, MG; Gauson, LA; Stevenson, LA; Ross, RA; Pertwee, RG (2010). «Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist». British Journal of Pharmacology. 159 (1): 129–41. doi:10.1111/j.1476-5381.2009.00515.x. PMC 2823359. PMID 20002104.
Baker, PB; Gough, TA; Taylor, BJ (1980). «Illicitly imported Cannabis products: Some physical and chemical features indicative of their origin». Bulletin on narcotics. 32 (2): 31–40. PMID 6907024.
Hillig, K. W.; Mahlberg, P. G. (2004). «A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae)». American Journal of Botany. 91 (6): 966–75. doi:10.3732/ajb.91.6.966. PMID 21653452.
Thomas, Adèle; Stevenson, Lesley A; Wease, Kerrie N; Price, Martin R; Baillie, Gemma; Ross, Ruth A; Pertwee, Roger G (2005). «Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1and CB2receptor antagonist». British Journal of Pharmacology. 146 (7): 917–26. doi:10.1038/sj.bjp.0706414. PMC 1751228. PMID 16205722.
Merkus, Frans W. H. M. (1971). «Cannabivarin and Tetrahydrocannabivarin, Two New Constituents of Hashish». Nature. 232 (5312): 579–80. doi:10.1038/232579a0. PMID 4937510.
Di Tomaso, Emmanuelle; Beltramo, Massimiliano; Piomelli, Daniele (1996). «Brain cannabinoids in chocolate». Nature. 382 (6593): 677–8. doi:10.1038/382677a0. PMID 8751435.
Chapman, K. D.; Venables, B; Markovic, R; Blair Jr, RW; Bettinger, C (1999). «N-Acylethanolamines in Seeds. Quantification of Molecular Species and Their Degradation upon Imbibition». Plant Physiology. 120 (4): 1157–64. doi:10.1104/pp.120.4.1157. PMC 59349. PMID 10444099.
Sepe, Nunzio; De Petrocellis, Luciano; Montanaro, Francesca; Cimino, Guido; Di Marzo, Vincenzo (1998). «Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs». Biochimica et Biophysica Acta (BBA) – Lipids and Lipid Metabolism. 1389 (2): 101–11. doi:10.1016/S0005-2760(97)00132-X. PMID 9461251.
Piomelli, Daniele; Schweitzer, Nephi; Piomelli, Paul (1997). «A second endogenous cannabinoid that modulates long-term potentiation». Nature. 388 (6644): 773–8. doi:10.1038/42015. PMID 9285589.
Savinainen, Juha R; Järvinen, Tomi; Laine, Krista; Laitinen, Jarmo T (2001). «Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1receptor-dependent G-protein activation in rat cerebellar membranes». British Journal of Pharmacology. 134 (3): 664–72. doi:10.1038/sj.bjp.0704297. PMC 1572991. PMID 11588122.
Hanuš, Lumír; Abu-Lafi, Saleh; Fride, Ester; Breuer, Aviva; Vogel, Zvi; Shalev, Deborah E.; Kustanovich, Irina; Mechoulam, Raphael (2001). «2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor». Proceedings of the National Academy of Sciences. 98 (7): 3662–5. doi:10.1073/pnas.061029898. PMC 31108. PMID 11259648.
Oka, Saori; Tsuchie, Akiko; Tokumura, Akira; Muramatsu, Mayumi; Suhara, Yoshitomo; Takayama, Hiroaki; Waku, Keizo; Sugiura, Takayuki (2003). «Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species». Journal of Neurochemistry. 85 (6): 1374–81. doi:10.1046/j.1471-4159.2003.01804.x. PMID 12787057.
Bisogno, Tiziana; Melck, Dominique; Bobrov, Mikhail Yu.; Gretskaya, Natalia M.; Bezuglov, Vladimir V.; De Petrocellis, Luciano; Di Marzo, Vincenzo (2000). «N-acyl-dopamines: Novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo». Biochemical Journal. 351 (3): 817–24. doi:10.1042/0264-6021:3510817. PMC 1221424. PMID 11042139.
Bisogno, T; Ligresti, A; Dimarzo, V (2005). «The endocannabinoid signalling system: Biochemical aspects». Pharmacology Biochemistry and Behavior. 81 (2): 224–38. doi:10.1016/j.pbb.2005.01.027. PMID 15935454.
Ralevic, Vera (2003). «Cannabinoid modulation of peripheral autonomic and sensory neurotransmission». European Journal of Pharmacology. 472 (1–2): 1–21. doi:10.1016/S0014-2999(03)01813-2. PMID 12860468.
Porter, A. C.; Sauer, JM; Knierman, MD; Becker, GW; Berna, MJ; Bao, J; Nomikos, GG; Carter, P; Bymaster, FP; Leese, AB; Felder, CC (2002). «Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor». Journal of Pharmacology and Experimental Therapeutics. 301 (3): 1020–4. doi:10.1124/jpet.301.3.1020. PMID 12023533.
Piñeiro, Roberto; Falasca, Marco (2012). «Lysophosphatidylinositol signalling: New wine from an old bottle». Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids. 1821 (4): 694–705. doi:10.1016/j.bbalip.2012.01.009. PMID 22285325.
Fride, E; Bregman, T; Kirkham, TC (2005). «Endocannabinoids and food intake: Newborn suckling and appetite regulation in adulthood». Experimental biology and medicine. 230 (4): 225–34. PMID 15792943.

ncbi.nlm.nih.gov

Pacher, P.; Bátkai, S; Kunos, G (2006). «The Endocannabinoid System as an Emerging Target of Pharmacotherapy». Pharmacological Reviews. 58 (3): 389–462. doi:10.1124/pr.58.3.2. PMC 2241751. PMID 16968947.
El-Alfy, Abir T.; Ivey, Kelly; Robinson, Keisha; Ahmed, Safwat; Radwan, Mohamed; Slade, Desmond; Khan, Ikhlas; Elsohly, Mahmoud; Ross, Samir (2010). «Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L». Pharmacology Biochemistry and Behavior. 95 (4): 434–42. doi:10.1016/j.pbb.2010.03.004. PMC 2866040. PMID 20332000.
Pacher, P.; Mechoulam, R. (2011). «Is lipid signaling through cannabinoid 2 receptors part of a protective system?». Progress in Lipid Research. 50 (2): 193–211. doi:10.1016/j.plipres.2011.01.001. PMC 3062638. PMID 21295074.
Campbell, V A; Gowran, A (2007). «Alzheimer's disease; taking the edge off with cannabinoids?». British Journal of Pharmacology. 152 (5): 655–62. doi:10.1038/sj.bjp.0707446. PMC 2190031. PMID 17828287.
Ryberg, E; Larsson, N; Sjögren, S; Hjorth, S; Hermansson, N-O; Leonova, J; Elebring, T; Nilsson, K; Drmota, T; Greasley, P J (2009). «The orphan receptor GPR55 is a novel cannabinoid receptor». British Journal of Pharmacology. 152 (7): 1092–101. doi:10.1038/sj.bjp.0707460. PMC 2095107. PMID 17876302.
Leweke, F M; Piomelli, D; Pahlisch, F; Muhl, D; Gerth, C W; Hoyer, C; Klosterkötter, J; Hellmich, M; Koethe, D (2012). «Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia». Translational Psychiatry. 2 (3): e94–. doi:10.1038/tp.2012.15. PMC 3316151. PMID 22832859.
Cascio, MG; Gauson, LA; Stevenson, LA; Ross, RA; Pertwee, RG (2010). «Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist». British Journal of Pharmacology. 159 (1): 129–41. doi:10.1111/j.1476-5381.2009.00515.x. PMC 2823359. PMID 20002104.
Thomas, Adèle; Stevenson, Lesley A; Wease, Kerrie N; Price, Martin R; Baillie, Gemma; Ross, Ruth A; Pertwee, Roger G (2005). «Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1and CB2receptor antagonist». British Journal of Pharmacology. 146 (7): 917–26. doi:10.1038/sj.bjp.0706414. PMC 1751228. PMID 16205722.
Chapman, K. D.; Venables, B; Markovic, R; Blair Jr, RW; Bettinger, C (1999). «N-Acylethanolamines in Seeds. Quantification of Molecular Species and Their Degradation upon Imbibition». Plant Physiology. 120 (4): 1157–64. doi:10.1104/pp.120.4.1157. PMC 59349. PMID 10444099.
Savinainen, Juha R; Järvinen, Tomi; Laine, Krista; Laitinen, Jarmo T (2001). «Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1receptor-dependent G-protein activation in rat cerebellar membranes». British Journal of Pharmacology. 134 (3): 664–72. doi:10.1038/sj.bjp.0704297. PMC 1572991. PMID 11588122.
Hanuš, Lumír; Abu-Lafi, Saleh; Fride, Ester; Breuer, Aviva; Vogel, Zvi; Shalev, Deborah E.; Kustanovich, Irina; Mechoulam, Raphael (2001). «2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor». Proceedings of the National Academy of Sciences. 98 (7): 3662–5. doi:10.1073/pnas.061029898. PMC 31108. PMID 11259648.
Bisogno, Tiziana; Melck, Dominique; Bobrov, Mikhail Yu.; Gretskaya, Natalia M.; Bezuglov, Vladimir V.; De Petrocellis, Luciano; Di Marzo, Vincenzo (2000). «N-acyl-dopamines: Novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo». Biochemical Journal. 351 (3): 817–24. doi:10.1042/0264-6021:3510817. PMC 1221424. PMID 11042139.

unodc.org

«Bulletin on Narcotics - 1962 Issue 3 - 004». UNODC (United Nations Office of Drugs and Crime). 1962 թ․ հունվարի 1. Վերցված է 2014 թ․ հունվարի 15-ին.
Baker, PB; Gough, TA; Taylor, BJ (1980). «Illicitly imported Cannabis products: Some physical and chemical features indicative of their origin». Bulletin on narcotics. 32 (2): 31–40. PMID 6907024.

web.archive.org

«More medicinal uses for marijuana». Marijuana.org. 2005 թ․ հոկտեմբերի 18. Արխիվացված է օրիգինալից 2005 թ․ դեկտեմբերի 21-ին. Վերցված է 2014 թ․ հունվարի 15-ին.

worldcat.org

Fellermeier, Monika; Eisenreich, Wolfgang; Bacher, Adelbert; Zenk, Meinhart H. (2001). «Biosynthesis of cannabinoids». European Journal of Biochemistry. 268 (6): 1596–1604. doi:10.1046/j.1432-1327.2001.02030.x. ISSN 0014-2956. PMID 11248677.